Vestmark Advisory Solutions’s iShares Biotechnology ETF IBB Stock Holding History

Vestmark Advisory Solutions’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.51M	Sell	7,930 -430	-5%	-$73.9K	0.01%	825
2026 Q1	$1.41M	Buy	8,360 +2,203	+36%	+$377K	0.02%	764
2025 Q4	$1.04M	Buy	6,157 +3,748	+156%	+$609K	0.01%	781
2025 Q3	$348K	Buy	+2,409	New	+$329K	0.01%	762
2023 Q3	–	Sell	-2,434	Closed	-$309K	–	631
2023 Q2	$309K	Buy	2,434 +254	+12%	+$33K	0.01%	703
2023 Q1	$282K	Buy	2,180 +200	+10%	+$26.2K	0.01%	720
2022 Q4	$260K	Sell	1,980 -272	-12%	-$35.2K	0.01%	720
2022 Q3	$263K	Buy	+2,252	New	+$280K	0.01%	705

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Vestmark Advisory Solutions's IBB Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its iShares Biotechnology ETF (IBB) stake by 5.1% in Q2 2026, selling an estimated $73.9K and leaving 7,930 shares worth $1.51M. The position accounts for 0.01% of the portfolio, ranked #825.

Vestmark Advisory Solutions first reported a position in IBB in Q3 2022 and has held it in 8 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Vestmark Advisory Solutions held 7,930 shares of iShares Biotechnology ETF worth $1.51M as of Q2 2026.
Vestmark Advisory Solutions sold 430 iShares Biotechnology ETF shares in Q2 2026, an estimated $73.9K.
iShares Biotechnology ETF made up 0.01% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #825 holding.
Vestmark Advisory Solutions first reported a position in iShares Biotechnology ETF in Q3 2022 and has held it in 8 quarters since.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.